Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Gabriel Fox & Peter Kranke. (2020) A pharmacological profile of intravenous amisulpride for the treatment of postoperative nausea and vomiting. Expert Review of Clinical Pharmacology 13:4, pages 331-340.
Read now
Read now
Gabriel M Fox, Ad F Roffel, Jan Hartstra, Linda A Bussian & Sjoerd P van Marle. (2019) Metabolism and Excretion of Intravenous, Radio-Labeled Amisulpride in Healthy, Adult Volunteers. Clinical Pharmacology: Advances and Applications 11, pages 161-169.
Read now
Read now
Arão Nogueira de Araújo, Eduardo Pondé de Sena, Irismar Reis de Oliveira & Mario F Juruena. (2012) Antipsychotic agents: efficacy and safety in schizophrenia. Drug, Healthcare and Patient Safety 4, pages 173-180.
Read now
Read now
Mario F Juruena, Eduardo Pondé de Sena & Irismar Reis de Oliveira. (2011) Specific mechanism of action of amisulpride in the treatment of schizophrenia and correlation with clinical response and tolerability. Journal of Receptor, Ligand and Channel Research 4, pages 49-55.
Read now
Read now
Articles from other publishers (20)
Syed Nasir Abbas Bukhari. (2022) Consequences of Antipsychotic Medications on Mental Health. Current Drug Safety 17:4, pages 285-293.
Crossref
Crossref
Kankan Qu, Qin Zhou, Lin Tian, Yuan Shen & Zhenhe Zhou. (2022) Amisulpride steady-state plasma concentration and adverse reactions in patients with schizophrenia: a study based on therapeutic drug monitoring data. International Clinical Psychopharmacology 37:6, pages 255-262.
Crossref
Crossref
Ming-Huan Zhu, Zhen-Jing Liu, Qiong-Yue Hu, Jia-Yu Yang, Ying Jin, Na Zhu, Ying Huang, Dian-Hong Shi, Min-Jia Liu, Hong-Yang Tan, Lei Zhao, Qin-Yu Lv, Zheng-Hui Yi, Feng-Chun Wu & Ze-Zhi Li. (2022) Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial. Military Medical Research 9:1.
Crossref
Crossref
Kankan Qu, Feng Wang, Zhiqiang Du, Shushan Wang, Zhongdong Zhang & Yuan Shen. (2021) A novel and sensitive method for determination of amisulpride in human plasma by two‐dimensional liquid chromatography. Biomedical Chromatography 35:10.
Crossref
Crossref
Jia-Wu Ji, Li-Ying Liu, Kai-Rong Hao, Yin-Liang Yu, Sai-Zheng Weng, Jian-Fan Wu & Reng-Chun Huang. (2021) Prediction of Self-Report Cognitive Function for the Symptomatic Remission in Schizophrenia Treated with Amisulpride: a Multicenter, 8-Week Case-Control Study. Psychiatric Quarterly 92:3, pages 935-945.
Crossref
Crossref
Lu-Feng Zhang, Chao-Fan Zhang, Wen-Xin Tang, Long He, Yang Liu, Dan-Dan Tian & Yan-Qiu Ai. (2020) Efficacy of amisulpride on postoperative nausea and vomiting: a systematic review and meta-analysis. European Journal of Clinical Pharmacology 76:7, pages 903-912.
Crossref
Crossref
Anaïs Glatard, Monia Guidi, Aurélie Delacrétaz, Céline Dubath, Claire Grosu, Nermine Laaboub, Armin von Gunten, Philippe Conus, Chantal Csajka & Chin B. Eap. (2019) Amisulpride: Real-World Evidence of Dose Adaptation and Effect on Prolactin Concentrations and Body Weight Gain by Pharmacokinetic/Pharmacodynamic Analyses. Clinical Pharmacokinetics 59:3, pages 371-382.
Crossref
Crossref
J. Herrstedt, Y. Summers, K. Jordan, J. von Pawel, A. H. Jakobsen, M. Ewertz, S. Chan, J. D. Naik, M. Karthaus, S. Dubey, R. Davis & G. M. Fox. (2018) Amisulpride prevents nausea and vomiting associated with highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled, dose-ranging trial. Supportive Care in Cancer 27:7, pages 2699-2705.
Crossref
Crossref
Ángel L. Montejo, Celso Arango, Miquel Bernardo, José L. Carrasco, Benidicto Crespo-Facorro, Juan J. Cruz, Javier Del Pino-Montes, Miguel A. García-Escudero, Clemente García-Rizo, Ana González-Pinto, Ana I. Hernández, Manuel Martín-Carrasco, Fermín Mayoral-Cleries, Jaqueline Mayoral-van Son, M. Teresa Mories, Isabella Pachiarotti, Jesús Pérez, Salvador Ros & Eduard Vieta. (2017) Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics. Frontiers in Neuroendocrinology 45, pages 25-34.
Crossref
Crossref
Erma Z. Drobnis & Ajay K. NangiaErma Z. Drobnis & Ajay K. Nangia. 2017. Impacts of Medications on Male Fertility. Impacts of Medications on Male Fertility
63
101
.
Edwin H.M. Lee, Christy L.M. Hui, Jessie J.X. Lin, Elaine Y.N. Ching, W.C. Chang, Sherry K.W. Chan & Eric Y.H. Chen. (2016) Quality of life and functioning in first-episode psychosis Chinese patients with different antipsychotic medications. Early Intervention in Psychiatry 10:6, pages 535-539.
Crossref
Crossref
Mahmoud Slim, Inmaculada Medina-Caliz, Andres Gonzalez-Jimenez, M. Rosario Cabello, Fermin Mayoral-Cleries, M. Isabel Lucena & Raul J. Andrade. (2016) Hepatic Safety of Atypical Antipsychotics: Current Evidence and Future Directions. Drug Safety 39:10, pages 925-943.
Crossref
Crossref
Ángel L. Montejo, Celso Arango, Miguel Bernardo, José L. Carrasco, Benedicto Crespo-Facorro, Juan J. Cruz, Javier del Pino, Miguel A. García Escudero, Clemente García Rizo, Ana González-Pinto, Ana I. Hernández, Manuel Martín Carrasco, Fermin Mayoral Cleries, Jaqueline Mayoral van Son, M. Teresa Mories, Isabella Pachiarotti, Salvador Ros & Eduard Vieta. (2016) Spanish consensus on the risks and detection of antipsychotic drug-related hyperprolactinaemia. Revista de Psiquiatría y Salud Mental (English Edition) 9:3, pages 158-173.
Crossref
Crossref
Ángel L. Montejo, Celso Arango, Miguel Bernardo, José L. Carrasco, Benedicto Crespo-Facorro, Juan J. Cruz, Javier del Pino, Miguel A. García Escudero, Clemente García Rizo, Ana González-Pinto, Ana I. Hernández, Manuel Martín Carrasco, Fermin Mayoral Cleries, Jaqueline Mayoral van Son, M. Teresa Mories, Isabella Pachiarotti, Salvador Ros & Eduard Vieta. (2016) Consenso español sobre los riesgos y detección de la hiperprolactinemia iatrogénica por antipsicóticos. Revista de Psiquiatría y Salud Mental 9:3, pages 158-173.
Crossref
Crossref
Ying Liang, Yun-Ai Su, Zhen-Guo Zhao, Nan Gao, Ji-Zhong Huang, Mao-Qin Tang, Ke-Qing Li, Fu-De Yang, Xin Yu & Tian-Mei Si. (2015) Acute Effects of Haloperidol, Amisulpride, and Quetiapine on Bone Turnover Markers in Patients With Schizophrenia. Journal of Clinical Psychopharmacology 35:5, pages 583-586.
Crossref
Crossref
J. Peuskens, L. Pani, J. Detraux & M. De Hert. (2014) The Effects of Novel and Newly Approved Antipsychotics on Serum Prolactin Levels: A Comprehensive Review. CNS Drugs.
Crossref
Crossref
Pawel ZajdelAnna Partyka, Krzysztof Marciniec, Andrzej J Bojarski, Maciej Pawlowski & Anna Wesolowska. (2014) Quinoline- and isoquinoline-sulfonamide analogs of aripiprazole: novel antipsychotic agents?. Future Medicinal Chemistry 6:1, pages 57-75.
Crossref
Crossref
Thomas R Einarson, Michiel EH Hemels, Isaac Nuamah, Srihari Gopal, Danielle Coppola & David Hough. (2012) An Analysis of Potentially Prolactin-Related Adverse Events and Abnormal Prolactin Values in Randomized Clinical Trials with Paliperidone Palmitate. Annals of Pharmacotherapy 46:10, pages 1322-1330.
Crossref
Crossref
J. J. Roix, G. A. DeCrescenzo, P. H. Cheung, J. R. Ciallella, T. Sulpice, S. Saha & R. Halse. (2012) Effect of the antipsychotic agent amisulpride on glucose lowering and insulin secretion. Diabetes, Obesity and Metabolism 14:4, pages 329-334.
Crossref
Crossref
Mario F. JuruenaEduardo Ponde00C9; De SenaIrismar Reis De Oliveira. (2011) Sertindole in the Management of Schizophrenia. Journal of Central Nervous System Disease 3, pages JCNSD.S5729.
Crossref
Crossref